BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7525960)

  • 1. The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates).
    Okruszek A; Olesiak M; Balzarini J
    J Med Chem; 1994 Oct; 37(22):3850-4. PubMed ID: 7525960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H; Levy JA
    Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT).
    Hiebl J; Zbiral E; Balzarini J; De Clercq E
    J Med Chem; 1992 Aug; 35(16):3016-23. PubMed ID: 1323681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
    Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
    J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
    Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
    Buckheit RW; Germany-Decker J; Hollingshead MG; Allen LB; Shannon WM; Janssen PA; Chirigos MA
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1097-106. PubMed ID: 7508723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
    Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
    J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
    J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives.
    Chamorro C; Pérez-Pérez MJ; Rodríguez-Barrios F; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    Antiviral Res; 2001 Jun; 50(3):207-22. PubMed ID: 11397508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
    Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
    Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT.
    McGuigan C; Pathirana RN; Balzarini J; De Clercq E
    J Med Chem; 1993 Apr; 36(8):1048-52. PubMed ID: 8478904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV proteinase inhibitors.
    Roberts NA; Craig JC; Duncan IB
    Biochem Soc Trans; 1992 May; 20(2):513-6. PubMed ID: 1397651
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-human immunodeficiency virus type 1 (HIV-1) activity of 3-substituted derivatives of 3'-azido-3'-deoxythymidine (AZT), and inhibition of HIV-1 reverse transcriptase by their 5'-triphosphates.
    Kitade Y; Suzuki A; Hirota K; Maki Y; Nakane H; Ono K; Baba M; Shigeta S
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):920-4. PubMed ID: 1381996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication.
    Pauwels R; Andries K; Debyser Z; Kukla M; Schols D; Desmyter J; De Clercq E; Janssen PA
    Biochem Soc Trans; 1992 May; 20(2):509-12. PubMed ID: 1383063
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and anti-HIV-1 activity of novel TSAO-T derivatives modified at the 2'- and 5'-positions of the sugar moiety.
    Ingate S; Pérez-Pérez MJ; De Clercq E; Balzarini J; Camarasa MJ
    Antiviral Res; 1995 Jun; 27(3):281-99. PubMed ID: 8540750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.